StockData

Black Hawk Acquisition Corp (BKHA) stock

BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 5/30
$8.65+1.45 (+20.14%)

Close on Nov 17, 2026Market cap $35.93MP/E –Yield –

Black Hawk Acquisition cash

Cash and short-term investments held at the end of each period.

Black Hawk Acquisition's cash was $0 at Aug 31, 2026. For fiscal 2025 it was $0, down 100.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Nov 30, 2025$0-100.0%
FY2024Nov 30, 2024$264.84K+111.7%
FY2023Nov 30, 2023$125.10K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$0-100.0%
Q2 FY2026CQ2 2026May 31, 2026$0-100.0%
Q1 FY2026CQ1 2026Feb 28, 2026$0-100.0%
Q4 FY2025CQ4 2025Nov 30, 2025$0-100.0%
Q3 FY2025CQ3 2025Aug 31, 2025$15.00K-95.4%
Q2 FY2025CQ2 2025May 31, 2025$72.91K-80.1%
Q1 FY2025CQ1 2025Feb 28, 2025$101.53K+70.9%
Q4 FY2024CQ4 2024Nov 30, 2024$264.84K+111.7%
Q3 FY2024CQ3 2024Aug 31, 2024$323.85K–
Q2 FY2024CQ2 2024May 31, 2024$366.67K–
Q1 FY2024CQ1 2024Feb 29, 2024$59.40K–
Q4 FY2023CQ4 2023Nov 30, 2023$125.10K–

More Black Hawk Acquisition figures

See a number that looks wrong?